Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides caloric support and corrects hypoglycemia by increasing blood glucose levels. Sodium chloride maintains osmotic pressure and fluid balance. Potassium chloride replaces potassium deficits and maintains electrolyte homeostasis.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
IV infusion; rate and volume determined by fluid, electrolyte, and caloric requirements. Typical adult: 100-200 mL/hour, not to exceed 25 g dextrose/hour (500 mL/hour of D5) and 10 mEq potassium/hour. Total daily dose: 1-3 L/day.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
None Documented
None Documented
Not applicable as a combined solution; dextrose half-life ~1-2 hours (plasma glucose clearance); potassium half-life depends on distribution and renal function (approx. 1-2 hours for serum K correction); sodium and chloride have no defined half-life.
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Renal (glucose and ions are handled by the kidneys; potassium excreted via urine; sodium and chloride reabsorbed or excreted as needed; dextrose metabolized to CO2 and water; <5% unchanged glucose excreted in urine if normoglycemic)
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Category A/B
Category C
Electrolyte
Electrolyte